Cargando…

Estimation of the Difference in Colistin Plasma Levels in Critically Ill Patients with Favorable or Unfavorable Clinical Outcomes

In recent decades, antimicrobial resistance (AMR) has led to an increased use of therapeutic alternatives. Among these options, colistin continues to be an option for the treatment of multi-resistant (MDR) Gram-negative bacterial infections. However, due to its high toxicity (nephrotoxicity and neur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sanabria, Jose, Garzón, Vivian, Pacheco, Tatiana, Avila, Maria-Paula, Garcia, Julio-Cesar, Jaimes, Diego, Torres, Angela, Bustos, Rosa-Helena, Escobar-Perez, Javier, Abril, Deisy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540821/ https://www.ncbi.nlm.nih.gov/pubmed/34683923 http://dx.doi.org/10.3390/pharmaceutics13101630

Ejemplares similares

Is There a Role for the Therapeutic Drug Monitoring of Colistin? An Overview
por: Avila, Maria-Paula, et al.
Publicado: (2020)

An Approach to Measuring Colistin Plasma Levels Regarding the Treatment of Multidrug-Resistant Bacterial Infection
por: Pacheco, Tatiana, et al.
Publicado: (2019)

Pseudomonas aeruginosa Coharboring Bla(KPC-2) and Bla(VIM-2) Carbapenemase Genes
por: Pacheco, Tatiana, et al.
Publicado: (2019)

Impact on Antibiotic Resistance, Therapeutic Success, and Control of Side Effects in Therapeutic Drug Monitoring (TDM) of Daptomycin: A Scoping Review
por: Osorio, Carolina, et al.
Publicado: (2021)

Granulations and Differential Diagnosis of Cases Favorable and Cases Unfavorable
por: Hinman, Thomas P.
Publicado: (1921)

Label-Free Quantification of Anti-TNF-α in Patients Treated with Adalimumab Using an Optical Biosensor
por: Bustos, Rosa Helena, et al.
Publicado: (2018)

Implementing Vancomycin Population Pharmacokinetic Models: An App for Individualized Antibiotic Therapy in Critically Ill Patients
por: Mena, Manuel, et al.
Publicado: (2023)

Favorable and unfavorable health conditions within OECD countries: An exploratory study
por: Park, Myung-Bae, et al.
Publicado: (2018)

Pharmacovigilance of Biopharmaceuticals in Rheumatic Diseases, Adverse Events, Evolution, and Perspective: An Overview
por: Rodríguez, Sandra, et al.
Publicado: (2020)

Clinical Evidence of Magistral Preparations Based on Medicinal Cannabis
por: Arias, Sara, et al.
Publicado: (2021)

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma
por: Schulte, Johannes H., et al.
Publicado: (2010)

Stratification of brachytherapy-treated intermediate-risk prostate cancer patients into favorable and unfavorable cohorts
por: Merrick, Gregory S., et al.
Publicado: (2015)

Favoring the unfavored: Selective electrochemical nitrogen fixation using a reticular chemistry approach
por: Lee, Hiang Kwee, et al.
Publicado: (2018)

Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2019)

More than Meets the Eye: Understanding Perceptions of China Beyond the Favorable–Unfavorable Dichotomy
por: Li, Xiaojun
Publicado: (2021)

Estrogen Receptor β Expression and Its Clinical Implication in Breast Cancers: Favorable or Unfavorable?
por: Choi, Young
Publicado: (2022)

Personalized Medicine for Antibiotics: The Role of Nanobiosensors in Therapeutic Drug Monitoring
por: Garzón, Vivian, et al.
Publicado: (2020)

Bacteremia by colistin-resistant Acinetobacter baumannii isolate: a case report
por: Garcia Casallas, Julio Cesar, et al.
Publicado: (2019)

First Report and Comparative Genomics Analysis of a bla(OXA-244)-Harboring Escherichia coli Isolate Recovered in the American Continent
por: Abril, Deisy, et al.
Publicado: (2019)

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review
por: Zabidi, Mohd Shafie, et al.
Publicado: (2021)

Optical Biosensors for Therapeutic Drug Monitoring
por: Garzón, Vivian, et al.
Publicado: (2019)

The Genetic Diagnosis of Neurodegenerative Diseases and Therapeutic Perspectives
por: García, Julio-César, et al.
Publicado: (2018)

Determinants of favorable or unfavorable opinion about euthanasia in a sample of French cancer patients receiving palliative care
por: de Nonneville, Alexandre, et al.
Publicado: (2018)

Unfavorable and favorable changes in modifiable risk factors and incidence of coronary heart disease: The Whitehall II cohort study
por: Virtanen, Marianna, et al.
Publicado: (2018)

Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
por: Lee, Hsin-Hua, et al.
Publicado: (2022)

Can HRV Predict Prolonged Hospitalization and Favorable or Unfavorable Short-Term Outcome in Patients with Acute Ischemic Stroke?
por: Aftyka, Joanna, et al.
Publicado: (2023)

A study of auxiliary factors for judges in sentencing dangerous driving offenses – the mediating role of favorable and unfavorable factors
por: Liu, Chengjie, et al.
Publicado: (2023)

Renal and neurological side effects of colistin in critically ill patients
por: Spapen, Herbert, et al.
Publicado: (2011)

Diagnostic value of tumor markers in identifying favorable or unfavorable subsets in patients with cancer of unknown primary: a retrospective study
por: Takamizawa, Shigemasa, et al.
Publicado: (2022)

Colistin Resistance in Aeromonas spp.
por: Gonzalez-Avila, Luis Uriel, et al.
Publicado: (2021)

Comparison of colistin-induced nephrotoxicity between two different formulations of colistin in critically ill patients: a retrospective cohort study
por: Feng, Jia-Yih, et al.
Publicado: (2021)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients
por: Jung, Sunmi, et al.
Publicado: (2019)

Efficacies of Colistin–Carbapenem versus Colistin–Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study
por: Wang, Sheng-Huei, et al.
Publicado: (2021)

Variations of Network Centralities Between Playing Positions in Favorable and Unfavorable Close and Unbalanced Scores During the 2018 FIFA World Cup
por: Clemente, Filipe Manuel, et al.
Publicado: (2019)

Comparative effectiveness of low-dose-rate brachytherapy with or without external beam radiotherapy in favorable and unfavorable intermediate-risk prostate cancer
por: Tsumura, Hideyasu, et al.
Publicado: (2022)

Synergistic Effects of Capric Acid and Colistin against Colistin-Susceptible and Colistin-Resistant Enterobacterales
por: Liu, Yi-Yun, et al.
Publicado: (2022)

Antimicrobial Contribution of Chitosan Surface-Modified Nanoliposomes Combined with Colistin against Sensitive and Colistin-Resistant Clinical Pseudomonas aeruginosa
por: Laverde-Rojas, Valentina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6drbjgv7iflbffhsmrklni5nbn